Agency
Su Clinica Familiar
Su Clinica Familiar was paid $37.58M by Medicaid between Jan 2018 and Dec 2024, across 227 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 68% of everything it billed.
33Billing provider infoSU CLINICA FAMILIAR
HARLINGEN, TX 78550
HARLINGEN, TX 78550
33aNPI1285643304assigned 08/07/2006
33bProvider typeCase Management Agency
28Total paid$37.58M
24GClaims786,529
24DCodes billed227
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Case Management Agency providers in Texas
Rank by total paid#8 of 219
Median peer was paid$1.45M
This provider vs. median26×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,005 | $329K | |
| 2019 | 2,395 | $334K | |
| 2020 | 55,656 | $2.51M | |
| 2021 | 162,639 | $8.13M | |
| 2022 | 212,454 | $11.39M | |
| 2023 | 142,039 | $6.26M | |
| 2024incomplete | 209,341 | $8.62M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 68% | 183,052 | 120,825 | $25.62M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.2% | 71,564 | 57,406 | $3.07M |
| D0999 | Unspecified diagnostic procedure, by report | 6.7% | 15,657 | 14,700 | $2.52M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5.2% | 48,436 | 39,940 | $1.96M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.6% | 9,030 | 8,459 | $611K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.4% | 7,463 | 7,109 | $512K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.2% | 8,940 | 7,891 | $449K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.1% | 6,657 | 6,204 | $427K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.1% | 3,301 | 3,154 | $424K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 4,712 | 4,353 | $375K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | <1% | 2,129 | 1,801 | $182K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 33,953 | 20,619 | $149K |
215 more codes
| 87428 | <1% | 5,820 | $139K | |
| 99381 | <1% | 1,145 | $132K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 2,278 | $131K |
| 99050 | <1% | 11,549 | $116K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 510 | $82K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 1,203 | $53K |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | <1% | 102 | $40K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,155 | $34K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 549 | $27K |
| 59430 | <1% | 597 | $27K | |
| 59025 | Fetal non-stress test | <1% | 1,331 | $24K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,396 | $22K |
| 99385 | <1% | 134 | $21K | |
| 90461 | <1% | 12,637 | $21K | |
| 0001A | <1% | 1,077 | $19K | |
| 87081 | <1% | 7,871 | $18K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 347 | $18K |
| 76801 | <1% | 738 | $18K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 6,697 | $17K |
| 0002A | <1% | 914 | $15K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 10,024 | $14K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 6,072 | $11K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 122 | $11K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,275 | $11K |
| 80053 | Comprehensive metabolic panel | <1% | 7,600 | $11K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 6,080 | $11K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 5,505 | $11K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 136 | $10K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 200 | $10K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,049 | $9K |
| 96160 | <1% | 6,061 | $8K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,035 | $8K |
| 81002 | <1% | 12,960 | $8K | |
| 81025 | <1% | 5,691 | $8K | |
| D2930 | Prefabricated stainless steel crown - primary tooth | <1% | 61 | $7K |
| 59514 | <1% | 23 | $7K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 552 | $6K |
| 80061 | Lipid panel | <1% | 7,999 | $6K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 1,573 | $6K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 1,178 | $6K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 65 | $5K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 9,292 | $5K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,049 | $5K |
| 0071A | <1% | 251 | $5K | |
| 0011A | <1% | 653 | $5K | |
| 81001 | <1% | 5,214 | $5K | |
| 84203 | <1% | 975 | $5K | |
| 0012A | <1% | 650 | $4K | |
| 90715 | <1% | 1,983 | $4K | |
| 92552 | <1% | 5,926 | $4K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,445 | $4K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 93 | $3K |
| 85018 | <1% | 5,933 | $3K | |
| 86762 | <1% | 1,214 | $3K | |
| 82105 | <1% | 724 | $3K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 1,949 | $3K |
| 0072A | <1% | 149 | $2K | |
| 83655 | <1% | 511 | $2K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 61 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 994 | $2K |
| 97169 | <1% | 125 | $2K | |
| 90620 | <1% | 618 | $2K | |
| D1351 | Sealant - per tooth | <1% | 2,124 | $2K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 130 | $2K |
| 86850 | <1% | 750 | $2K | |
| 87340 | <1% | 696 | $2K | |
| 93000 | <1% | 432 | $2K | |
| 90656 | <1% | 1,207 | $2K | |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 7,546 | $2K |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 1,897 | $2K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 26 | $2K |
| D0120 | Dental checkup, returning patient | <1% | 7,074 | $1K |
| 86592 | <1% | 4,421 | $1K | |
| D1110 | Prophylaxis - adult | <1% | 2,361 | $1K |
| 0054A | <1% | 48 | $1K | |
| 82950 | <1% | 1,480 | $1K | |
| 90619 | <1% | 1,277 | $1K | |
| 84479 | <1% | 2,056 | $1K | |
| 99384 | <1% | 17 | $1K | |
| 72081 | <1% | 91 | $1K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 851 | $1K |
| D0274 | Bitewings - four radiographic images | <1% | 3,375 | $1K |
| 84702 | <1% | 527 | $1K | |
| 84436 | <1% | 1,824 | $1K | |
| 87807 | <1% | 209 | $1K | |
| 90686 | <1% | 10,813 | $1K | |
| 82677 | <1% | 202 | $954.60 | |
| 84030 | <1% | 717 | $789.49 | |
| 86803 | <1% | 332 | $779.35 | |
| 84439 | <1% | 966 | $768.94 | |
| D0220 | Intraoral - periapical first radiographic image | <1% | 1,875 | $765.48 |
| 87210 | <1% | 1,146 | $762.84 | |
| 0013A | <1% | 75 | $720.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,311 | $719.51 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 80 | $712.78 |
| 86580 | <1% | 237 | $705.22 | |
| D1120 | Dental cleaning, child | <1% | 4,024 | $700.00 |
| 86336 | <1% | 201 | $615.65 | |
| 86900 | <1% | 677 | $513.72 | |
| 86901 | <1% | 670 | $506.00 | |
| 80050 | General health panel | <1% | 310 | $476.05 |
| D9420 | <1% | 16 | $449.41 | |
| 87220 | <1% | 782 | $444.14 | |
| 0004A | <1% | 18 | $440.00 | |
| 90480 | <1% | 23 | $440.00 | |
| 0074A | <1% | 21 | $440.00 | |
| 0064A | <1% | 44 | $440.00 | |
| 74018 | <1% | 53 | $394.28 | |
| 87420 | <1% | 127 | $370.61 | |
| 82043 | <1% | 747 | $365.23 | |
| D0272 | Bitewings - two radiographic images | <1% | 1,583 | $347.16 |
| 76830 | Ultrasound, transvaginal | <1% | 14 | $296.76 |
| 82948 | <1% | 117 | $291.87 | |
| 90651 | <1% | 2,024 | $267.84 | |
| 82570 | <1% | 788 | $253.98 | |
| 0134A | <1% | 12 | $240.00 | |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 1,253 | $232.01 |
| D0140 | Limited oral evaluation - problem focused | <1% | 33 | $231.90 |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 1,115 | $229.14 |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 203 | $205.60 |
| 82607 | <1% | 188 | $202.72 | |
| 82951 | <1% | 189 | $172.96 | |
| D0330 | Panoramic radiographic image | <1% | 301 | $168.00 |
| 99000 | <1% | 48 | $126.00 | |
| 99441 | <1% | 77 | $122.70 | |
| D9248 | <1% | 120 | $121.88 | |
| 69209 | <1% | 25 | $116.19 | |
| D0170 | <1% | 324 | $99.24 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 306 | $87.69 |
| 82952 | <1% | 157 | $49.35 | |
| D1330 | <1% | 4,271 | $49.25 | |
| 81003 | <1% | 411 | $41.58 | |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 49 | $41.00 |
| 86140 | <1% | 40 | $39.15 | |
| A4267 | Contraceptive supply, condom, male, each | <1% | 82 | $38.34 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 139 | $20.27 |
| 82947 | <1% | 26 | $19.80 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 91 | $14.58 |
| 99442 | <1% | 27 | $12.38 | |
| 85652 | <1% | 30 | $9.08 | |
| 90621 | <1% | 1,244 | $6.20 | |
| 96127 | <1% | 1,246 | $0.87 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 46 | $0.27 |
| 90707 | <1% | 697 | $0.03 | |
| 3078F | <1% | 13,008 | $0.01 | |
| 90734 | 0% | 1,046 | $0.00 | |
| 3725F | 0% | 8,089 | $0.00 | |
| 1159F | 0% | 1,629 | $0.00 | |
| 90710 | 0% | 996 | $0.00 | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | 0% | 296 | $0.00 |
| 1160F | 0% | 886 | $0.00 | |
| 99173 | 0% | 10,021 | $0.00 | |
| 0502F | 0% | 4,982 | $0.00 | |
| 90648 | 0% | 1,316 | $0.00 | |
| 90670 | 0% | 2,561 | $0.00 | |
| 99051 | 0% | 3,660 | $0.00 | |
| 90681 | 0% | 67 | $0.00 | |
| 3077F | 0% | 626 | $0.00 | |
| 90633 | 0% | 1,796 | $0.00 | |
| 90700 | 0% | 757 | $0.00 | |
| 3511F | 0% | 54 | $0.00 | |
| 3046F | 0% | 266 | $0.00 | |
| 91300 | 0% | 2,043 | $0.00 | |
| 3051F | 0% | 148 | $0.00 | |
| D9230 | Inhalation of nitrous oxide / analgesia, anxiolysis | 0% | 298 | $0.00 |
| 90713 | 0% | 61 | $0.00 | |
| 90685 | 0% | 17 | $0.00 | |
| 4013F | 0% | 82 | $0.00 | |
| 82274 | 0% | 12 | $0.00 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 0% | 45 | $0.00 |
| 99177 | 0% | 21 | $0.00 | |
| 91313 | 0% | 12 | $0.00 | |
| 81222 | 0% | 12 | $0.00 | |
| 86038 | 0% | 12 | $0.00 | |
| 84550 | 0% | 12 | $0.00 | |
| 90716 | 0% | 758 | $0.00 | |
| 3074F | 0% | 13,288 | $0.00 | |
| D0603 | 0% | 9,613 | $0.00 | |
| 3044F | 0% | 6,487 | $0.00 | |
| 90696 | 0% | 749 | $0.00 | |
| 1036F | 0% | 10,091 | $0.00 | |
| 90697 | 0% | 1,885 | $0.00 | |
| 3079F | 0% | 1,210 | $0.00 | |
| D0601 | 0% | 50 | $0.00 | |
| 1126F | 0% | 4,058 | $0.00 | |
| 4010F | 0% | 571 | $0.00 | |
| 3008F | 0% | 11,054 | $0.00 | |
| 91307 | 0% | 526 | $0.00 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 401 | $0.00 |
| 91301 | 0% | 480 | $0.00 | |
| 1034F | 0% | 167 | $0.00 | |
| 3075F | 0% | 838 | $0.00 | |
| 90723 | 0% | 454 | $0.00 | |
| 99172 | 0% | 1,928 | $0.00 | |
| 90677 | 0% | 848 | $0.00 | |
| 0500F | 0% | 33 | $0.00 | |
| 90680 | 0% | 2,066 | $0.00 | |
| 1000F | 0% | 445 | $0.00 | |
| 1125F | 0% | 574 | $0.00 | |
| 91305 | 0% | 131 | $0.00 | |
| D0602 | 0% | 136 | $0.00 | |
| 3080F | 0% | 225 | $0.00 | |
| 90698 | 0% | 158 | $0.00 | |
| 1111F | 0% | 842 | $0.00 | |
| S3620 | Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) | 0% | 130 | $0.00 |
| 0503F | 0% | 109 | $0.00 | |
| 83001 | 0% | 13 | $0.00 | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 0% | 17 | $0.00 |
| 0240U | 0% | 35 | $0.00 | |
| 91306 | 0% | 15 | $0.00 | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 0% | 50 | $0.00 |
| 3052F | 0% | 36 | $0.00 | |
| 83002 | 0% | 12 | $0.00 | |
| 90744 | 0% | 12 | $0.00 | |
| 90660 | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSALDIVAR, ADAM (CFO)
| Provider | Location | Paid |
|---|---|---|
| Su Clinica Familiar | Harlingen, TX | $3.10M |
| Su Clinica Familiar | Brownsville, TX | $2.28M |
| Su Clinica Familiar | Raymondville, TX | $1.56M |
| Su Clinica Familiar | Harlingen, TX | $435.72 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.